School of Medicine


Showing 6,821-6,840 of 12,891 Results

  • Xiangde Luo

    Xiangde Luo

    Postdoctoral Scholar, Radiation Physics

    BioXiangde Luo is a postdoctoral researcher in Professor Ruijiang Li’s lab at Stanford Medicine, where he specializes in computational pathology. His work centers on developing AI‑driven methods for imaging biomarker discovery and precision oncology. Previously, he has developed some deep learning models to enable annotation‑efficient learning and advance biomedical image analysis. For a comprehensive overview of my research, please visit my Google Scholar profile: https://scholar.google.com/citations?hl=en&user=dD4HLS4AAAAJ. If you’d like to learn more or discuss potential collaborations, please don’t hesitate to get in touch.

  • XIAOHUA LUO

    XIAOHUA LUO

    Affiliate, Institute for Immunity, Transplantation, and Infection Operations
    Visiting Scholar, Institute for Immunity, Transplantation, and Infection Operations

    BioAcademic Appointments
    - Visiting Scholar, Stanford University School of Medicine (Holden Maecker Lab)
    - Chief Physician / Associate Professor / Associate Research Scientist, The First Affiliated Hospital of Chongqing Medical University

    Professional Education
    - Visiting Scholar, Karolinska Institutet (Per Ljungman & Markus Maeurer Lab) (2016)
    - Ph. D., Peking University Health Science Centre (2009)
    - B.Med., Tongji Medical College, Huazhong University of Science and Technology (2001)

    Selected Publications:
    - Luo XH*, Zhu Y, Duan XQ, Peng W, Pei CX, Yang L, Li Q, Zhao M, Wang L. Histone HIST1 genes and tumor-infiltrating lymphocytes in a child with γδ T cell acute lymphoblastic leukemia by single-cell sequencing. Journal of Leukocyte Biology. 2025 Apr;117(4):qiaf022.
    - Shui LP, Zhu Y, Duan XQ, Chen YT, Yang L, Tang XQ, Zhang HB, Xiao Q, Wang L, Liu L, Luo XH*. HBsAg (‐)/HBsAb (‐)/HBeAg (‐)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B ‐ cell lymphoma receiving rituximab based immunochemotherapy. Journal of Medical Virology. 2023 Feb 3.
    - Luo XH*, Poiret T, Liu Z, Meng Q, Nagchowdhury A, Ljungman P. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. Frontiers in Immunology. 2022;13.
    - Luo XH*, Zhu Y, Chen YT, Shui LP, Liu L. CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update. Frontiers in immunology. 2021;12.
    - Luo XH*, Meng Q, Liu Z, Paraschoudi G. Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21. Clinical Immunology. 2020 Aug 1;217:108456.
    - Li S, Huang J, Zhang YL, Zhu Y, An YF, Du J, Zhang ZL, Xia Y, Liu L, Wang L, Luo XH*. Wiskott- Aldrich syndrome protein may be critical for CD8+ T cell function following MCMV infection. Cellular immunology. 2019 Apr 1;338:43-50.
    - Luo XH, Meng Q, Rao M, Liu Z, Paraschoudi G, Dodoo E, Maeurer M. The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer. Immunology. 2018 Nov;155(3):294-308.
    - Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, Jäger E. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine. 2018 Jul 1;33:49-56.
    - Liu Zhenjiang, Martin Rao, Xiaohua Luo, Elisabeth Sandberg, Jiri Bartek Jr, Esther Schoutrop, Anna von Landenberg, Qingda Meng, Davide Valentini, Thomas Poiret, Georges Sinclair, Inti- Harvey Peredo, Ernest Dodoo, and Markus Maeurer*. Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis. EBioMedicine. 2017 Sep; 23: 20–24.
    - Liu Z, Poiret T, Persson O, Meng Q, Rane L, Bartek J, Karbach J, Altmannsberger HM, Illies C, Luo X, Harvey-Peredo I. NY-ESO-1-and survivin-specific T-cell responses in the peripheral blood from patients with glioma. Cancer Immunology, Immunotherapy. 2018 Feb 1;67(2):237- 46.
    - Liu Z, Meng Q, Bartek Jr J, Poiret T, Persson O, Rane L, Rangelova E, Illies C, Peredo IH, Luo X, Rao MV. Tumor-infiltrating lymphocytes (TILs) from patients with glioma. Oncoimmunology. 2017 Feb 1;6(2):e1252894.
    - XH Luo, XJ Huang*, KY Liu, LP Xu, DH Liu. Protective immunity transferred by infusion of CMV- specific CD8+ T cells within donor grafts: its associations with CMV reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16(7):994-1004
    - XH Luo, YJ Chang, LP Xu, DH Liu, KY Liu, XJ Huang*. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical haematopoietic SCT. Bone Marrow Transplant 2009; 43(1):29-36.

  • Tiffany Luong

    Tiffany Luong

    Postdoctoral Scholar, Infectious Diseases

    BioTiffany Luong obtained her Ph.D. from UCSD/SDSU in the lab of Dwayne Roach where she studied the formulation, purification, and application of bacteriophages targeting the ESKAPE pathogen Pseudomonas aeruginosa. Currently, her research in the Bollyky Lab focuses on the development of preclinical models to study chronic infections of P. aeruginosa and the immunogenicity of bacteriophages to the mammalian host.

  • Garima J. Lupas, PhD, ABPP-CN

    Garima J. Lupas, PhD, ABPP-CN

    Clinical Assistant Professor (Affiliated), Adult Neurology

    BioDr. Garima J. Lupas is a board-certified, fellowship-trained neuropsychologist with Stanford Health Care. She is also a clinical assistant professor (affiliated) in the Department of Neurology & Neurological Sciences, Division of Neuropsychology at Stanford University School of Medicine.

    Dr. Lupas specializes in conducting neuropsychological assessments for a variety of conditions, including neurodegenerative diseases, movement disorders, psychiatric disorders, cerebrovascular disease, and infectious neurological diseases. She also performs presurgical evaluations for deep brain stimulation and epilepsy surgical candidates. She takes a comprehensive approach to assessing cognitive and behavioral function, considering each person’s overall well-being and quality of life when making treatment recommendations.

    Dr. Lupas has studied the effects of age and dementia on cognitive function, especially memory. Her research has also assessed how age impacts thinking, social, and daily life skills in people with schizophrenia. Additionally, Dr. Lupas has examined the role of culture in identity and intimacy development among young adults from India, China, and the United States.

    Dr. Lupas has published her findings in peer-reviewed journals, including The Clinical Neuropsychologist and Identity: An International Journal of Theory and Research. She has also presented at numerous conferences across the nation, including meetings of the American Academy of Clinical Neuropsychology (AACN), American Psychological Association, and International Neuropsychological Society. Using her expertise in aging, she has authored a book chapter in the Encyclopedia of Geropsychology on depression and cognition in older adults.

    Dr. Lupas is a member of AACN.

  • Kevin M Lutley

    Kevin M Lutley

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Lutley is a primary care doctor. He is board certified in internal medicine.

    For every patient, he creates a customized care plan. Plans focus on helping each person enjoy the best possible health and wellness.

    Dr. Lutley has helped advance care through research. He has shared his research discoveries with his peers in invited presentations. Topics include drug prices in community pharmacies and the quality of interactions between patients and resident physicians.

    While an internal medicine resident at Stanford, Dr. Lutley served as a member of the Stanford Ambulatory Care Excellence Program. This initiative aims to enhance the quality of outpatient primary care.

    Dr. Lutley helps educate the primary care doctors of tomorrow. He is a clinical assistant professor of primary care and population health in the Stanford Department of Medicine, Division of Primary Care.

    Before joining Stanford, Dr. Lutley performed needs assessments and care coordination with local public health agencies in Flint, Michigan.

    Recognition for his achievements includes induction in the Gold Humanism Honor Society. This national organization honors senior medical students, residents, teachers and others for excellence in clinical care, leadership, and compassion. Additional honors for Dr. Lutley include induction in Alpha Omega Alpha, the honor society in the field of medicine.

    From Stanford University, he received the Julian Wolfsohn Award. This honor goes to residents who demonstrate exemplary professionalism, teaching, and dedication to patient care.

    Dr. Lutley is a member of the American College of Physicians.

  • Amelie Lutz

    Amelie Lutz

    Adjunct Clinical Associate Professor, Radiology

    Current Research and Scholarly InterestsMolecular imaging in oncology
    Peripheral Nerve Imaging
    Cellular imaging of musculoskeletal inflammatory diseases
    Kinematic musculoskeletal imaging
    Magnetic resonance imaging of hepatic disorders

  • Matthias Christian Lutz

    Matthias Christian Lutz

    Graduate, Medicine, Dermatology

    BioI am a medical student at the Technical University of Munich and currently pursuing my doctoral research under the supervision of Dr. Paul Schmiedmayer at the Stanford Mussallem Center for Biodesign. Throughout my studies, I have consistently focused on the intersection of artificial intelligence and medicine.
    My current research at Stanford University is situated in the field of cardiovascular medicine and explores how contextualized large language models can help detect early progression of the Cardio-Kidney-Metabolic (CKM) syndrome and support more precise clinical decision-making. The overarching goal is to translate data-driven approaches into clinical practice and enable more personalized and preventive care.
    As part of my medical training, I ranked among the top 1.5% nationwide in the first written medical licensing examination in Germany. In parallel, I gained over two years of practical experience at Brainlab in Clinical Affairs, where I supported international clinical trials and regulatory approval processes in the MedTech sector.
    In addition, I am co-founder and chair of OneAIM (one-aim.org), a student-led MedTech initiative that has grown into the largest organization of its kind in Germany, now operating across two locations. Through various programs, OneAIM promotes interdisciplinary programs at the intersection of medicine, technology and innovation.
    Beyond research and entrepreneurial activities, I am actively involved in advancing medical education. As the only student member of the curriculum commission at the Technical University of Munich, I take on a leading role in integrating digital medicine into the medical curriculum in a structured and exam-relevant manner. Additionally, I served as the instructor for the elective course “Neural Networks - AI in Medicine” at LMU Munich, where I introduced students to the intersection of clinical medicine and artificial intelligence.

  • Hannah Luxenberg-Tono

    Hannah Luxenberg-Tono

    Affiliate, Medicine - Primary Care and Population Health

    BioHannah Luxenberg is a researcher in human-computer interaction and implementation science exploring how emerging technologies can support patient pain management in palliative care. Her work focuses on designing and evaluating accessible, patient-centered technologies through interdisciplinary and global collaboration.

  • Daphne P. Ly, MD, FACS

    Daphne P. Ly, MD, FACS

    Affiliate

    Current Research and Scholarly Interests1. Integrate machine learning with electronic health record system to improve work flow and achieve individualize cancer care based on current evidence.
    2. Apply Cancer Genetics in cancer treatment and cancer risk reduction.